Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

23.78
+0.56002.41%
Post-market: 24.000.2200+0.93%19:39 EDT
Volume:321.59K
Turnover:7.62M
Market Cap:1.11B
PE:8.88
High:23.89
Open:23.09
Low:23.09
Close:23.22
52wk High:53.96
52wk Low:20.39
Shares:46.50M
Float Shares:35.34M
Volume Ratio:0.74
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.68
EPS(LYR):3.29
ROE:18.32%
ROA:7.31%
PB:1.46
PE(LYR):7.22

Loading ...

Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage?

Simply Wall St.
·
Oct 13

Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says

MT Newswires Live
·
Oct 09

BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32

MT Newswires Live
·
Oct 09

Amphastar price target lowered to $31 from $32 at BofA

TIPRANKS
·
Oct 09

Amphastar Pharmaceuticals Director Floyd F. Petersen Reports Sale of Common Shares

Reuters
·
Oct 03

Amphastar Pharmaceuticals Inc - on Sept 15, Enters Contract Research Agreement With Hanxin - SEC Filing

THOMSON REUTERS
·
Sep 19

Is Weakness In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.
·
Sep 19

Director Floyd F. Petersen Reports Disposal of Common Shares in Amphastar Pharmaceuticals Inc

Reuters
·
Sep 04

Amphastar Pharmaceuticals to Participate in Analyst-Moderated Fireside Chat at Wells Fargo Healthcare Conference

Reuters
·
Aug 28

Amphastar Pharmaceuticals Is Maintained at Neutral by B of A Securities

Dow Jones
·
Aug 26

Amphastar Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $32 From $28

THOMSON REUTERS
·
Aug 26

Stock Track | Amphastar Pharmaceuticals Soars 6.54% on Exclusive Licensing Deal and Analyst Upgrade

Stock Track
·
Aug 12

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
Aug 12

Stock Track | Amphastar Pharmaceuticals Soars 5.63% Pre-market on Exclusive Licensing Deal and Analyst Upgrade

Stock Track
·
Aug 12

Needham Upgrades Amphastar Pharmaceuticals to Buy From Hold, Price Target is $36

MT Newswires Live
·
Aug 12

BRIEF-Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology

Reuters
·
Aug 12

Amphastar Pharmaceuticals Inc : Needham Raises to Buy From Hold

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Inc - to Pay up to $267 Mln in Milestone Payments - SEC Filing

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Inc - on August 8, Entered License Agreement With Nanjing Anji Biotechnology - SEC Filing

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Secures Exclusive Licensing Deal with Anji for Innovative Peptide Therapies in Oncology and Ophthalmology

Reuters
·
Aug 12